Ligand validation:6OJS

MTX: METHOTREXATE

MTX is a Ligand Of Interest in 6OJS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OJS_MTX_A_604	46%	19%	0.206	0.941	1.6	1.83	5	9	2	0	100%	1
6OJS_MTX_B_604	40%	19%	0.23	0.942	1.6	1.84	5	9	2	0	100%	1
6OJS_MTX_C_604	37%	19%	0.238	0.939	1.6	1.83	5	8	2	0	100%	1
6OJS_MTX_E_604	27%	19%	0.233	0.88	1.6	1.83	5	9	2	0	100%	1
6OJS_MTX_D_604	25%	19%	0.265	0.905	1.6	1.88	5	10	2	0	100%	1
6PFG_MTX_C_604	69%	19%	0.151	0.965	1.6	1.85	5	9	3	0	100%	1
3HJ3_MTX_B_609	67%	13%	0.141	0.95	1.9	2.06	10	10	3	0	100%	1
6PFE_MTX_E_604	61%	16%	0.166	0.956	1.93	1.76	4	8	2	0	100%	1
2OIP_MTX_A_605	59%	22%	0.181	0.963	1.38	1.87	3	10	4	0	100%	1
6PFA_MTX_A_604	55%	19%	0.173	0.941	1.62	1.86	5	10	1	0	100%	1
1RA3_MTX_A_161	97%	9%	0.058	0.974	1.61	2.84	8	23	1	0	100%	1
1U72_MTX_A_188	97%	20%	0.065	0.979	1.13	2.23	2	16	2	0	100%	1
1RG7_MTX_A_161	94%	7%	0.071	0.968	1.88	2.93	9	17	1	0	100%	1
1DDR_MTX_B_200	93%	2%	0.077	0.971	2.29	4.49	7	20	0	1	100%	1
3IA4_MTX_A_164	91%	17%	0.077	0.962	1.84	1.8	3	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.